No More ER Analysts

Wanted to grasp on what everyone thought about this - as I can see both sides of the spectrum of this argument.

Read an article from BI stating that with CRM (i.e. SalesForce, etc.) technology advancing in the ER workforce and ultimately cutting out some ER spots in firms. Firms are going to be paying even less to get reports from analyst since they have almost enough information that they need for their analysis unless they'd prefer the written version rather than having it automated.

Hedge funds are going more towards the ETF/index-tracking route, but I feel boutiques should be okay despite this anticipated change.

Thoughts?

See Business Insider article:
http://www.businessinsider.com/equity-research-an…

 
  1. This topic has already been discussed numerous times
  2. Business Insider sucks
  3. Yes, there are going to be fewer stock analysts. But the unique advantage humans have over machines (AI, or whatever you call it) is the ability to have a 3-12 month view, whereas machines are superior in the short time horizon. Therefore, I am confident that ER as a whole is not going to shut down completely.
 
Best Response
pacificoast:

1. This topic has already been discussed numerous times
2. Business Insider sucks
3. Yes, there are going to be fewer stock analysts. But the unique advantage humans have over machines (AI, or whatever you call it) is the ability to have a 3-12 month view, whereas machines are superior in the short time horizon. Therefore, I am confident that ER as a whole is not going to shut down completely.

I wanted to echo what pacificoast wrote.

Also keep in mind that the decline of equity research is more of a result of declining equity commissions/failure of actively managed industry to consistently beat benchmark then it is AI/automation shrinking jobs. As the article also mentioned, do we really need 30-40 analyst covering Apple when the majority share undifferentiated views?

 

This. ER is paid for by commissions...with declining commissions there is less money for ER. Pretty simple really It's not about automation of research. Numbers only tell part of the story. Calls with management, experts, etc. are really what connect the dots that are the numbers.

The hypothetical scenario where true research went away would be a great case study of the law of unintended consequences. Good research is needed and it would be a really shitty market if it went away.

 
pacificoast:

3. Yes, there are going to be fewer stock analysts. But the unique advantage humans have over machines (AI, or whatever you call it) is the ability to have a 3-12 month view, whereas machines are superior in the short time horizon. Therefore, I am confident that ER as a whole is not going to shut down completely.

This is complete and total rubbish. Its obvious that you have absolutely no idea what quants do.

 

The downfall/decline in ER revenues is due to the failure of active management to generate returns appropriate for their fees. The next frontier in Asset Management is low fees and passive management (mostly because of the low fees associated with it), and both of those lead to lower ER revenues.

"There's nothing you can do if you're too scared to try." - Nickel Creek
 

I'd guess that in 10 years there are 50%-75% as many sell side research analysts/associates. And those that are still working will be making 50%-75% of what an equivalent person makes now. The business model is fundamentally flawed as it is and will be even more so as active mgmt fees trend lower. But research can't and won't just go away.

 

Rerum delectus quas velit dignissimos ab officiis. Velit aut omnis suscipit suscipit cumque non. Quia dicta est nesciunt asperiores dolore soluta.

Similique dolores maiores accusantium ratione sed aut rerum. Excepturi qui et nam minima eos minus. Quia ut assumenda sit placeat fugit dolorum non. Esse qui est consequuntur ad nam qui nesciunt. In deserunt facere sunt aut quia sapiente voluptates. Magnam voluptatem blanditiis quasi dolore. Ad quas dolorum voluptatum odit ut ut.

Suscipit ut minima neque vero cupiditate est enim. In blanditiis culpa reprehenderit in maiores. Reiciendis amet excepturi voluptatibus.

Rerum provident necessitatibus eius ut cupiditate. Modi minima at expedita quaerat voluptas iste non totam.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
kanon's picture
kanon
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”